It could be an industry giant in the making.
Companies with exciting prospects aren’t always of the popular, headline-grabbing variety. Some little-known stocks are worth serious consideration, too.
Take Axsome Therapeutics (AXSM), a mid-cap biotech company not involved in the rapidly growing area of GLP-1 weight loss drugs. Though it’s doing so quietly, this drugmaker has performed more or less in line with the broader market this year, and there are good reasons to believe it could produce…
Read More…
Source: https://www.fool.com/investing/2024/09/29/1-under-the-radar-biotech-stock-to-buy-and-hold/